MedPath

The effect of green coffee supplement on diabetic

Phase 2
Completed
Conditions
diabetes.
Type 2 diabetes mellitus with unspecified complications
E11.8
Registration Number
IRCT20200728048232N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Definitive diagnosis of type 2 diabetes in patients was made by an associate clinical physician under ADA criteria.
Duration of type 2 diabetes is at least 3 years
The type and dose of drugs used in the last 6 months is constant
No chronic (chronic, renal, hepatic, pulmonary, or chronic or acute inflammatory diseases, especially acute inflammation of the pancreas and endocarditis)No heart disease, short bowel syndrome, allergies and thyroid disease
Do not use any dietary supplements in the last 6 months
No pregnancy and lactation
Willingness to participate in the study
No allergies to green coffee

Exclusion Criteria

Pregnancy during the study period
Changes in medication dosage during the study period
Occurrence of one of the above diseases during the study period
Dissatisfaction with continuing to participate in the study
Do not take less than 80% of the allocated amount of green coffee tablets or do not follow the study design for more than a week

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood Glu. Timepoint: at the first and end of the study. Method of measurement: Fasting blood glucose by glucose oxidase method.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath